Replies to post #2659 on BrainStorm Cell Therapeutics Inc (BCLI)

[Chief-money]

Yes of course, lots of signs where this is going: 1-last conference call stated “excited” to share ALS HE data in next 30-45 days, 2-recent $10M investment into company at $8/share with option to purchase more at $15, 3-“excited” to share MS phase 2 interim data expected next 30-45 days, 4-new indication to be announced. 5-Israeli govt approved 13 additional for ALS treatment on HE.